BERNZOTT CAPITAL ADVISORS – Halozyme Therapeutics, Inc. Transaction History
BERNZOTT CAPITAL ADVISORS portfolio value:
$21.33M
portfolio value
BERNZOTT CAPITAL ADVISORS quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +44.75% | 166.85K shares | 4.93M | $39.54 | 539.66K |
| Q2 2022 | share | Increase | +45.53% | 116.63K shares | 6.18M | $44 | 372.81K |
| Q1 2022 | share | Increase | 0.00% | 256.18K shares | 10.21M | $39.88 | 256.18K |